Regulation of self-renewal in normal and cancer stem cells

FEBS Journal

Volumn 279, Issue 19, 2012, Pages 3559-3572

  Verga Falzacappa, Maria V ^a   Ronchini, Chiara ^b   Reavie, Linsey B ^a   Pelicci, Pier G ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

Author keywords

asymmetric division; cancer stem cell; cancer therapy; DNA damage; genomic instability; p21; p53; self renewal; stem cell; symmetric division

Indexed keywords

ALPHA INTERFERON; ANTINEOPLASTIC AGENT; CELL DNA; FLUOROURACIL; GRANULOCYTE COLONY STIMULATING FACTOR; TUMOR MARKER; VALPROIC ACID;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CANCER INHIBITION; CANCER STEM CELL; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL DIVISION; CELL FUNCTION; CELL ISOLATION; CELL PROLIFERATION; CELL RENEWAL; DNA DAMAGE; DRUG TARGETING; HUMAN; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL;

CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; NEOPLASTIC STEM CELLS; STEM CELLS;

EID: 84866410772     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2012.08727.x     Document Type: Article

References (117)

1. Blanpain C, Horsley V, &, Fuchs E, (2007) Epithelial stem cells: turning over new leaves. Cell 128, 445-458. (Pubitemid 46198895)
2. Orkin SH, &, Zon LI, (2008) Hematopoiesis: an evolving paradigm for stem cell biology. Cell 132, 631-644. (Pubitemid 351260057)
3. Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J, Minden M, Paterson B, Caligiuri MA, &, Dick JE, (1994) A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367, 645-648. (Pubitemid 24067706)
4. Huntly BJ, &, Gilliland DG, (2004) Blasts from the past: new lessons in stem cell biology from chronic myelogenous leukemia. Cancer Cell 6, 199-201. (Pubitemid 39222031)
5. Krivtsov AV, Twomey D, Feng Z, Stubbs MC, Wang Y, Faber J, Levine JE, Wang J, Hahn WC, Gilliland DG, et al. (2006) Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. Nature 442, 818-822. (Pubitemid 44258912)
6. Zhang M, Behbod F, Atkinson RL, Landis MD, Kittrell F, Edwards D, Medina D, Tsimelzon A, Hilsenbeck S, Green JE, et al. (2008) Identification of tumor-initiating cells in a p53-null mouse model of breast cancer. Cancer Res 68, 4674-4682.
7. Dick JE, (2008) Stem cell concepts renew cancer research. Blood 112, 4793-4807.
8. Shackleton M, Quintana E, Fearon ER, &, Morrison SJ, (2009) Heterogeneity in cancer: cancer stem cells versus clonal evolution. Cell 138, 822-829.
9. Bruce WR, &, Van Der Gaag H, (1963) A quantitative assay for the number of murine lymphoma cells capable of proliferation in vivo. Nature 199, 79-80.
10. Reya T, Morrison SJ, Clarke MF, &, Weissman IL, (2001) Stem cells, cancer, and cancer stem cells. Nature 414, 105-111. (Pubitemid 33041634)
11. Blanpain C, &, Fuchs E, (2009) Epidermal homeostasis: a balancing act of stem cells in the skin. Nat Rev Mol Cell Biol 10, 207-217.
12. Luo J, Yin X, Ma T, &, Lu J, (2010) Stem cells in normal mammary gland and breast cancer. Am J Med Sci 339, 366-370.
13. van der Flier LG, &, Clevers H, (2009) Stem cells, self-renewal, and differentiation in the intestinal epithelium. Annu Rev Physiol 71, 241-260.
14. Cicalese A, Bonizzi G, Pasi CE, Faretta M, Ronzoni S, Giulini B, Brisken C, Minucci S, Di Fiore PP, &, Pelicci PG, (2009) The tumor suppressor p53 regulates polarity of self-renewing divisions in mammary stem cells. Cell 138, 1083-1095.
15. Liu Y, Elf SE, Miyata Y, Sashida G, Huang G, Di Giandomenico S, Lee JM, Deblasio A, Menendez S, Antipin J, et al. (2009) p53 regulates hematopoietic stem cell quiescence. Cell Stem Cell 4, 37-48.
16. Molofsky AV, Pardal R, Iwashita T, Park IK, Clarke MF, &, Morrison SJ, (2003) Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature 425, 962-967. (Pubitemid 37376927)
17. Park IK, Qian D, Kiel M, Becker MW, Pihalja M, Weissman IL, Morrison SJ, &, Clarke MF, (2003) Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature 423, 302-305. (Pubitemid 40852701)
18. Matsumoto A, Takeishi S, Kanie T, Susaki E, Onoyama I, Tateishi Y, Nakayama K, &, Nakayama KI, (2011) p57 is required for quiescence and maintenance of adult hematopoietic stem cells. Cell Stem Cell 9, 262-271.
19. Zou P, Yoshihara H, Hosokawa K, Tai I, Shinmyozu K, Tsukahara F, Maru Y, Nakayama K, Nakayama KI, &, Suda T, (2011) p57(Kip2) and p27(Kip1) cooperate to maintain hematopoietic stem cell quiescence through interactions with Hsc70. Cell Stem Cell 9, 247-261.
20. Cheng T, Rodrigues N, Dombkowski D, Stier S, &, Scadden DT, (2000) Stem cell repopulation efficiency but not pool size is governed by p27(kip1). Nat Med 6, 1235-1240.
21. Cheng T, Rodrigues N, Shen H, Yang Y, Dombkowski D, Sykes M, &, Scadden DT, (2000) Hematopoietic stem cell quiescence maintained by p21cip1/waf1. Science 287, 1804-1808.
22. Quintana E, Shackleton M, Sabel MS, Fullen DR, Johnson TM, &, Morrison SJ, (2008) Efficient tumour formation by single human melanoma cells. Nature 456, 593-598.
23. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, &, Dirks PB, (2004) Identification of human brain tumour initiating cells. Nature 432, 396-401. (Pubitemid 39551674)
24. Bonnet D, &, Dick JE, (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3, 730-737. (Pubitemid 27298715)
25. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, &, Clarke MF, (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100, 3983-3988. (Pubitemid 36418143)
26. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, &, De Maria R, (2007) Identification and expansion of human colon-cancer-initiating cells. Nature 445, 111-115. (Pubitemid 46067311)
27. Pece S, Tosoni D, Confalonieri S, Mazzarol G, Vecchi M, Ronzoni S, Bernard L, Viale G, Pelicci PG, &, Di Fiore PP, (2010) Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content. Cell 140, 62-73.
28. Miyamoto T, Weissman IL, &, Akashi K, (2000) AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation. Proc Natl Acad Sci USA 97, 7521-7526. (Pubitemid 30431496)
29. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, &, Dirks PB, (2003) Identification of a cancer stem cell in human brain tumors. Cancer Res 63, 5821-5828. (Pubitemid 37187480)
30. Collins AT, Berry PA, Hyde C, Stower MJ, &, Maitland NJ, (2005) Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 65, 10946-10951. (Pubitemid 41713363)
31. Wang Z, Smith KS, Murphy M, Piloto O, Somervaille TC, &, Cleary ML, (2008) Glycogen synthase kinase 3 in MLL leukaemia maintenance and targeted therapy. Nature 455, 1205-1209.
32. Traver D, Akashi K, Weissman IL, &, Lagasse E, (1998) Mice defective in two apoptosis pathways in the myeloid lineage develop acute myeloblastic leukemia. Immunity 9, 47-57. (Pubitemid 28361294)
33. Lim E, Vaillant F, Wu D, Forrest NC, Pal B, Hart AH, Asselin-Labat ML, Gyorki DE, Ward T, Partanen A, et al. (2009) Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat Med 15, 907-913.
34. Chaffer CL, Brueckmann I, Scheel C, Kaestli AJ, Wiggins PA, Rodrigues LO, Brooks M, Reinhardt F, Su Y, Polyak K, et al. (2011) Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state. Proc Natl Acad Sci USA 108, 7950-7955.
35. McCulloch EA, Siminovitch L, &, Till JE, (1964) Spleen-colony formation in anemic mice of genotype Ww. Science 144, 844-846.
36. McCulloch EA, Siminovitch L, Till JE, Russell ES, &, Bernstein SE, (1965) The cellular basis of the genetically determined hemopoietic defect in anemic mice of genotype Sl-Sld. Blood 26, 399-410.
37. Till JE, &, McCulloch EA, (1961) A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat Res 14, 213-222.
38. Seita J, &, Weissman IL, (2010) Hematopoietic stem cell: self-renewal versus differentiation. Wiley Interdiscip Rev Syst Biol Med 2, 640-653.
39. Spangrude GJ, Heimfeld S, &, Weissman IL, (1988) Purification and characterization of mouse hematopoietic stem cells. Science 241, 58-62.
40. Ikuta K, &, Weissman IL, (1992) Evidence that hematopoietic stem cells express mouse c-kit but do not depend on steel factor for their generation. Proc Natl Acad Sci USA 89, 1502-1506.
41. Osawa M, Hanada K, Hamada H, &, Nakauchi H, (1996) Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science 273, 242-245. (Pubitemid 26285891)
42. Christensen JL, &, Weissman IL, (2001) Flk-2 is a marker in hematopoietic stem cell differentiation: a simple method to isolate long-term stem cells. Proc Natl Acad Sci USA 98, 14541-14546. (Pubitemid 33121428)
43. Wagers AJ, Sherwood RI, Christensen JL, &, Weissman IL, (2002) Little evidence for developmental plasticity of adult hematopoietic stem cells. Science 297, 2256-2259.
44. Adolfsson J, Mansson R, Buza-Vidas N, Hultquist A, Liuba K, Jensen CT, Bryder D, Yang L, Borge OJ, Thoren LA, et al. (2005) Identification of Flt3+ lympho-myeloid stem cells lacking erythro-megakaryocytic potential a revised road map for adult blood lineage commitment. Cell 121, 295-306. (Pubitemid 40546396)
45. Kiel MJ, Yilmaz OH, Iwashita T, Terhorst C, &, Morrison SJ, (2005) SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 121, 1109-1121. (Pubitemid 40884400)
46. Neering SJ, Bushnell T, Sozer S, Ashton J, Rossi RM, Wang PY, Bell DR, Heinrich D, Bottaro A, &, Jordan CT, (2007) Leukemia stem cells in a genetically defined murine model of blast-crisis CML. Blood 110, 2578-2585. (Pubitemid 47523181)
47. Jamieson CH, Ailles LE, Dylla SJ, Muijtjens M, Jones C, Zehnder JL, Gotlib J, Li K, Manz MG, Keating A, et al. (2004) Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N Engl J Med 351, 657-667. (Pubitemid 39063268)
48. Stingl J, Eirew P, Ricketson I, Shackleton M, Vaillant F, Choi D, Li HI, &, Eaves CJ, (2006) Purification and unique properties of mammary epithelial stem cells. Nature 439, 993-997. (Pubitemid 43292419)
49. Shackleton M, Vaillant F, Simpson KJ, Stingl J, Smyth GK, Asselin-Labat ML, Wu L, Lindeman GJ, &, Visvader JE, (2006) Generation of a functional mammary gland from a single stem cell. Nature 439, 84-88. (Pubitemid 43053633)
50. Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG, Liu S, et al. (2007) ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1, 555-567. (Pubitemid 350056407)
51. Spangrude GJ, Brooks DM, &, Tumas DB, (1995) Long-term repopulation of irradiated mice with limiting numbers of purified hematopoietic stem cells: in vivo expansion of stem cell phenotype but not function. Blood 85, 1006-1016.
52. Holyoake T, Jiang X, Eaves C, &, Eaves A, (1999) Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia. Blood 94, 2056-2064. (Pubitemid 29430422)
53. Guan Y, Ralph S, &, Hogge DE, (2002) Polyclonal normal hematopoietic progenitors in patients with acute myeloid leukemia. Exp Hematol 30, 721-728. (Pubitemid 34831692)
54. Tumbar T, Guasch G, Greco V, Blanpain C, Lowry WE, Rendl M, &, Fuchs E, (2004) Defining the epithelial stem cell niche in skin. Science 303, 359-363. (Pubitemid 38095773)
55. Wilson A, Laurenti E, Oser G, van der Wath RC, Blanco-Bose W, Jaworski M, Offner S, Dunant CF, Eshkind L, Bockamp E, et al. (2008) Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair. Cell 135, 1118-1129.
56. Welm BE, Tepera SB, Venezia T, Graubert TA, Rosen JM, &, Goodell MA, (2002) Sca-1(pos) cells in the mouse mammary gland represent an enriched progenitor cell population. Dev Biol 245, 42-56. (Pubitemid 34461802)
57. Alvi AJ, Clayton H, Joshi C, Enver T, Ashworth A, Vivanco MM, Dale TC, &, Smalley MJ, (2003) Functional and molecular characterisation of mammary side population cells. Breast Cancer Res 5, R1-R8.
58. Dontu G, Abdallah WM, Foley JM, Jackson KW, Clarke MF, Kawamura MJ, &, Wicha MS, (2003) In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 17, 1253-1270. (Pubitemid 36583168)
59. Kordon EC, &, Smith GH, (1998) An entire functional mammary gland may comprise the progeny from a single cell. Development 125, 1921-1930. (Pubitemid 28274378)
60. Knoblich JA, (2010) Asymmetric cell division: recent developments and their implications for tumour biology. Nat Rev Mol Cell Biol 11, 849-860.
61. Lechler T, &, Fuchs E, (2005) Asymmetric cell divisions promote stratification and differentiation of mammalian skin. Nature 437, 275-280. (Pubitemid 41294492)
62. Quyn AJ, Appleton PL, Carey FA, Steele RJ, Barker N, Clevers H, Ridgway RA, Sansom OJ, &, Nathke IS, (2010) Spindle orientation bias in gut epithelial stem cell compartments is lost in precancerous tissue. Cell Stem Cell 6, 175-181.
63. Shinin V, Gayraud-Morel B, Gomes D, &, Tajbakhsh S, (2006) Asymmetric division and cosegregation of template DNA strands in adult muscle satellite cells. Nat Cell Biol 8, 677-687.
64. Wu M, Kwon HY, Rattis F, Blum J, Zhao C, Ashkenazi R, Jackson TL, Gaiano N, Oliver T, &, Reya T, (2007) Imaging hematopoietic precursor division in real time. Cell Stem Cell 1, 541-554. (Pubitemid 350056405)
65. Castellanos E, Dominguez P, &, Gonzalez C, (2008) Centrosome dysfunction in Drosophila neural stem cells causes tumors that are not due to genome instability. Curr Biol 18, 1209-1214.
66. Egger B, Gold KS, &, Brand AH, (2010) Notch regulates the switch from symmetric to asymmetric neural stem cell division in the Drosophila optic lobe. Development 137, 2981-2987.
67. Pece S, Serresi M, Santolini E, Capra M, Hulleman E, Galimberti V, Zurrida S, Maisonneuve P, Viale G, &, Di Fiore PP, (2004) Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesis. J Cell Biol 167, 215-221. (Pubitemid 39435065)
68. Schimanski CC, Schmitz G, Kashyap A, Bosserhoff AK, Bataille F, Schafer SC, Lehr HA, Berger MR, Galle PR, Strand S, et al. (2005) Reduced expression of Hugl-1, the human homologue of Drosophila tumour suppressor gene lgl, contributes to progression of colorectal cancer. Oncogene 24, 3100-3109. (Pubitemid 40695079)
69. Glazer RI, Vo DT, &, Penalva LO, (2012) Musashi1: an RBP with versatile functions in normal and cancer stem cells. Front Biosci 17, 54-64.
70. Wilson A, Murphy MJ, Oskarsson T, Kaloulis K, Bettess MD, Oser GM, Pasche AC, Knabenhans C, Macdonald HR, &, Trumpp A, (2004) c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation. Genes Dev 18, 2747-2763. (Pubitemid 39507768)
71. Laurenti E, Varnum-Finney B, Wilson A, Ferrero I, Blanco-Bose WE, Ehninger A, Knoepfler PS, Cheng PF, MacDonald HR, Eisenman RN, et al. (2008) Hematopoietic stem cell function and survival depend on c-Myc and N-Myc activity. Cell Stem Cell 3, 611-624.
72. Pasi CE, Dereli-Oz A, Negrini S, Friedli M, Fragola G, Lombardo A, Van Houwe G, Naldini L, Casola S, Testa G, et al. (2011) Genomic instability in induced stem cells. Cell Death Differ 18, 745-753.
73. Cheng L, Lloyd RV, Weaver AL, Pisansky TM, Cheville JC, Ramnani DM, Leibovich BC, Blute ML, Zincke H, &, Bostwick DG, (2000) The cell cycle inhibitors p21WAF1 and p27KIP1 are associated with survival in patients treated by salvage prostatectomy after radiation therapy. Clin Cancer Res 6, 1896-1899. (Pubitemid 30305087)
74. Rossi DJ, Bryder D, Seita J, Nussenzweig A, Hoeijmakers J, &, Weissman IL, (2007) Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age. Nature 447, 725-729. (Pubitemid 46889729)
75. Shepherd BE, Kiem HP, Lansdorp PM, Dunbar CE, Aubert G, LaRochelle A, Seggewiss R, Guttorp P, &, Abkowitz JL, (2007) Hematopoietic stem-cell behavior in nonhuman primates. Blood 110, 1806-1813. (Pubitemid 47443891)
76. Trumpp A, Essers M, &, Wilson A, (2010) Awakening dormant haematopoietic stem cells. Nat Rev Immunol 10, 201-209.
77. Kippin TE, Martens DJ, &, van der Kooy D, (2005) p21 loss compromises the relative quiescence of forebrain stem cell proliferation leading to exhaustion of their proliferation capacity. Genes Dev 19, 756-767. (Pubitemid 40395086)
78. Viale A, De Franco F, Orleth A, Cambiaghi V, Giuliani V, Bossi D, Ronchini C, Ronzoni S, Muradore I, Monestiroli S, et al. (2009) Cell-cycle restriction limits DNA damage and maintains self-renewal of leukaemia stem cells. Nature 457, 51-56.
79. Bonizzi G, Cicalese A, Insinga A, &, Pelicci PG, (2012) The emerging role of p53 in stem cells. Trends Mol Med 18, 6-12.
80. Seita J, Rossi DJ, &, Weissman IL, (2010) Differential DNA damage response in stem and progenitor cells. Cell Stem Cell 7, 145-147.
81. Yamazaki S, Iwama A, Takayanagi S, Morita Y, Eto K, Ema H, &, Nakauchi H, (2006) Cytokine signals modulated via lipid rafts mimic niche signals and induce hibernation in hematopoietic stem cells. EMBO J 25, 3515-3523. (Pubitemid 44264862)
82. Tothova Z, Kollipara R, Huntly BJ, Lee BH, Castrillon DH, Cullen DE, McDowell EP, Lazo-Kallanian S, Williams IR, Sears C, et al. (2007) FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell 128, 325-339. (Pubitemid 46137992)
83. Mohrin M, Bourke E, Alexander D, Warr MR, Barry-Holson K, Le Beau MM, Morrison CG, &, Passegue E, (2010) Hematopoietic stem cell quiescence promotes error-prone DNA repair and mutagenesis. Cell Stem Cell 7, 174-185.
84. Sotiropoulou PA, Candi A, Mascre G, De Clercq S, Youssef KK, Lapouge G, Dahl E, Semeraro C, Denecker G, Marine JC, et al. (2010) Bcl-2 and accelerated DNA repair mediates resistance of hair follicle bulge stem cells to DNA-damage-induced cell death. Nat Cell Biol 12, 572-582.
85. Woodward WA, Chen MS, Behbod F, Alfaro MP, Buchholz TA, &, Rosen JM, (2007) WNT/beta-catenin mediates radiation resistance of mouse mammary progenitor cells. Proc Natl Acad Sci USA 104, 618-623. (Pubitemid 46123074)
86. Blanpain C, Mohrin M, Sotiropoulou PA, &, Passegue E, (2011) DNA-damage response in tissue-specific and cancer stem cells. Cell Stem Cell 8, 16-29.
87. Lane AA, &, Scadden DT, (2010) Stem cells and DNA damage: persist or perish? Cell 142, 360-362.
88. Ishikawa K, Ishii H, &, Saito T, (2006) DNA damage-dependent cell cycle checkpoints and genomic stability. DNA Cell Biol 25, 406-411. (Pubitemid 44175332)
89. Larsson LG, (2011) Oncogene- and tumor suppressor gene-mediated suppression of cellular senescence. Semin Cancer Biol 21, 367-376.
90. Serrano M, Lin AW, McCurrach ME, Beach D, &, Lowe SW, (1997) Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88, 593-602. (Pubitemid 27152402)
91. Bartkova J, Horejsi Z, Koed K, Kramer A, Tort F, Zieger K, Guldberg P, Sehested M, Nesland JM, Lukas C, et al. (2005) DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434, 864-870. (Pubitemid 40558993)
92. Braig M, Lee S, Loddenkemper C, Rudolph C, Peters AH, Schlegelberger B, Stein H, Dorken B, Jenuwein T, &, Schmitt CA, (2005) Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 436, 660-665. (Pubitemid 41117262)
93. Chen Z, Trotman LC, Shaffer D, Lin HK, Dotan ZA, Niki M, Koutcher JA, Scher HI, Ludwig T, Gerald W, et al. (2005) Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 436, 725-730. (Pubitemid 41117277)
94. Collado M, Gil J, Efeyan A, Guerra C, Schuhmacher AJ, Barradas M, Benguria A, Zaballos A, Flores JM, Barbacid M, et al. (2005) Tumour biology: senescence in premalignant tumours. Nature 436, 642. (Pubitemid 41117258)
95. Gorgoulis VG, Vassiliou LV, Karakaidos P, Zacharatos P, Kotsinas A, Liloglou T, Venere M, Ditullio RA Jr, Kastrinakis NG, Levy B, et al. (2005) Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 434, 907-913. (Pubitemid 40559004)
96. Lazzerini Denchi E, Attwooll C, Pasini D, &, Helin K, (2005) Deregulated E2F activity induces hyperplasia and senescence-like features in the mouse pituitary gland. Mol Cell Biol 25, 2660-2672. (Pubitemid 40381630)
97. Michaloglou C, Vredeveld LC, Soengas MS, Denoyelle C, Kuilman T, van der Horst CM, Majoor DM, Shay JW, Mooi WJ, &, Peeper DS, (2005) BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 436, 720-724. (Pubitemid 41117276)
98. Di Micco R, Fumagalli M, Cicalese A, Piccinin S, Gasparini P, Luise C, Schurra C, Garre M, Nuciforo PG, Bensimon A, et al. (2006) Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 444, 638-642. (Pubitemid 44864443)
99. Dankort D, Filenova E, Collado M, Serrano M, Jones K, &, McMahon M, (2007) A new mouse model to explore the initiation, progression, and therapy of BRAFV600E-induced lung tumors. Genes Dev 21, 379-384.
100. Rube CE, Fricke A, Widmann TA, Furst T, Madry H, Pfreundschuh M, &, Rube C, (2011) Accumulation of DNA damage in hematopoietic stem and progenitor cells during human aging. PLoS One 6, e17487.
101. Stratton MR, Campbell PJ, &, Futreal PA, (2009) The cancer genome. Nature 458, 719-724.
102. Kakarala M, &, Wicha MS, (2008) Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy. J Clin Oncol 26, 2813-2820.
103. Clayton S, &, Mousa SA, (2011) Therapeutics formulated to target cancer stem cells: is it in our future? Cancer Cell Int 11, 7.
104. Leiva M, Moretti S, Soilihi H, Pallavicini I, Peres L, Mercurio C, Dal Zuffo R, Minucci S, &, de The H, (2012) Valproic acid induces differentiation and transient tumor regression, but spares leukemia-initiating activity in mouse models of APL. Leukemia 26, 1630-1637.
105. Bug G, Gul H, Schwarz K, Pfeifer H, Kampfmann M, Zheng X, Beissert T, Boehrer S, Hoelzer D, Ottmann OG, et al. (2005) Valproic acid stimulates proliferation and self-renewal of hematopoietic stem cells. Cancer Res 65, 2537-2541. (Pubitemid 40490047)
106. Kuendgen A, Strupp C, Aivado M, Bernhardt A, Hildebrandt B, Haas R, Germing U, &, Gattermann N, (2004) Treatment of myelodysplastic syndromes with valproic acid alone or in combination with all-trans retinoic acid. Blood 104, 1266-1269. (Pubitemid 39166498)
107. Trumpp A, &, Wiestler OD, (2008) Mechanisms of Disease: cancer stem cells-targeting the evil twin. Nat Clin Pract Oncol 5, 337-347. (Pubitemid 351780950)
108. Essers MA, Offner S, Blanco-Bose WE, Waibler Z, Kalinke U, Duchosal MA, &, Trumpp A, (2009) IFNalpha activates dormant haematopoietic stem cells in vivo. Nature 458, 904-908.
109. Lowenberg B, van Putten W, Theobald M, Gmur J, Verdonck L, Sonneveld P, Fey M, Schouten H, de Greef G, Ferrant A, et al. (2003) Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia. N Engl J Med 349, 743-752. (Pubitemid 37010778)
110. Anguille S, Lion E, Willemen Y, Van Tendeloo VF, Berneman ZN, &, Smits EL, (2011) Interferon-alpha in acute myeloid leukemia: an old drug revisited. Leukemia 25, 739-748.
111. Zuber J, Shi J, Wang E, Rappaport AR, Herrmann H, Sison EA, Magoon D, Qi J, Blatt K, Wunderlich M, et al. (2011) RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia. Nature 478, 524-528.
112. Ito T, Kwon HY, Zimdahl B, Congdon KL, Blum J, Lento WE, Zhao C, Lagoo A, Gerrard G, Foroni L, et al. (2010) Regulation of myeloid leukaemia by the cell-fate determinant Musashi. Nature 466, 765-768.
113. Naka K, Hoshii T, Muraguchi T, Tadokoro Y, Ooshio T, Kondo Y, Nakao S, Motoyama N, &, Hirao A, (2010) TGF-beta-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia. Nature 463, 676-680.
114. Zhao C, Blum J, Chen A, Kwon HY, Jung SH, Cook JM, Lagoo A, &, Reya T, (2007) Loss of beta-catenin impairs the renewal of normal and CML stem cells in vivo. Cancer Cell 12, 528-541. (Pubitemid 350199070)
115. Pantel K, &, Alix-Panabieres C, (2007) The clinical significance of circulating tumor cells. Nat Clin Pract Oncol 4, 62-63. (Pubitemid 46189529)
116. Aguirre-Ghiso JA, (2007) Models, mechanisms and clinical evidence for cancer dormancy. Nat Rev Cancer 7, 834-846. (Pubitemid 350006258)
117. Ding L, Ley TJ, Larson DE, Miller CA, Koboldt DC, Welch JS, Ritchey JK, Young MA, Lamprecht T, McLellan MD, et al. (2012) Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature 481, 506-510.